Transplantation for CML: 2010

Research output: Contribution to journalComment/debate

1 Scopus citations

Abstract

In this issue of Blood, Saussele and colleagues from the German CML study group present data obtained from an interim safety analysis of a prospective multiarm trial in which allogeneic stem cell transplantation was used up front in selected low-risk CMLpatients, up front in patients presenting with advanced disease, or as planned second-line therapy after imatinib failure.

Original languageEnglish (US)
Pages (from-to)1860-1861
Number of pages2
JournalBlood
Volume115
Issue number10
DOIs
StatePublished - Mar 11 2010

    Fingerprint

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this